Tag: Cyberknife

The CyberKnife consists of a lightweight linear accelerator mounted on a robotic arm. Near real-time images allow for patient movement tracking within 1mm spatial accuracy. The CyberKnife references the position of the treatment target to internal radiographic features such as the skull, bony landmarks or implanted fiducials rather than a frame. The CyberKnife uses real-time x-rays to establish the position of the lesion during treatment and then dynamically brings the radiation beam into alignment with the observed position of the treatment target. The CyberKnife aims each beam independently. When the target moves, the process detects the change and accommodates it. This treatment system has been used to successfully treat lesions in patients who are otherwise not candidates for surgery or for lesions that are not amenable to open surgical techniques.

25 Aug 2026

By Ronny Allan

0 Comments

External Beam Radiation Therapy (EBRT) for Neuroendocrine Neoplasms

Clinical Trials and Research, Patient Advocacy, TreatmentCyberknife, External Beam Radiation Therapy (EBRT), Stereotactic body radiotherapy (SBRT)

Disclaimer: The information in this section is for education only and does not represent a standard care pathway or service. These treatments are not suitable for everyone, and careful patient selection by an experienced multidisciplinary team is essential. Always discuss your individual situation with your own specialist team. External Beam Radiation Therapy (EBRT) is an established medical treatment with roots dating back to the late 19th century, but modern EBRT is far more precise, and new technologies now allow safer treatment of tumours that were previously difficult to target. It uses high‑energy beams to damage cancer cells. The…

07 Mar 2021

By Ronny Allan

0 Comments

Treatment for Neuroendocrine Cancer – a summary for patients

Treatment5-Fluorouracil (5-FU), Atezolizumab (Tecentriq), Avelumab (Bavencio), Capecitabine (Xeloda), CAPecitabine TEMozolomide (CAPTEM)., Chemotherapy, Cisplatin, Cisplatin/Etoposide, Cryoablation, Cyberknife, Etoposide, External beam radiotherapy, FOLFIRI, FOLFOX, Gamma knife, Interferon alpha (IFNα), Irinotecan (Campto), Irreversible electroporation (IRE), Lanreotide, Liver directed therapy, Lu-177, Lutathera, NanoKnife®, Nivolumab (Opdivo), Octreotide (Octreotide acetate), Opdivo (Nivolumab), Paclitaxel (Taxol), Pembrolizumab (Keytruda), Peptide receptor radionuclide therapy (PRRT), Proton beam therapy, Radiation therapy, Somatostatin analogues, Somatostatin receptors (SSTR), Somatuline Autogel (US: depot), Stereotactic body radiotherapy (SBRT), Stereotactic radiosurgery (SRS), Streptozotocin (Zanosar), Surgery, Targeted therapy, Temozolomide (Temodal), Thorson-Bioerck syndrome, Tumour mutational burden (TMB), Vepesid), Watchful waiting

1. Scope This summary provides an overview of the types of therapy known for treating Neuroendocrine Cancer. They will have been approved at least by one national or regional approval agency, may not be available or approved in your own country; and may appear in clinical guidelines for the treatment of Neuroendocrine Cancer. Clinical trials will not be covered, although it's noted that some of the approved treatments listed may be in follow on trials either to prove new coverage or used in combination with another drug. For a list of clinical trials covered by the author, click here.…

Our website use cookies to improve and personalize your experience and to display advertisements(if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.

Ok, I Agree